Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer - Join Clinical Trial NCTNCT05946213
How to Join This Clinical Trial - NCTNCT05946213
Learn how to participate in this PHASE3 trial studying an investigational therapy for Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05946213 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 332 locations. Find a study site near you:
Clinical Research Site
Birmingham, Alabama 35233 - United States
Status: RECRUITING
Clinical Research Site
Birmingham, Alabama 35243 - United States
Status: RECRUITING
Clinical Research Site
Tuscaloosa, Alabama 35401 - United States
Status: RECRUITING
Clinical Research Site
Little Rock, Arkansas 72205 - United States
Status: RECRUITING
Clinical Research Site
Antioch, California 94531 - United States
Status: RECRUITING
Clinical Research Site
Beverly Hills, California 90211 - United States
Status: RECRUITING
Clinical Research Site
Dublin, California 94568 - United States
Status: RECRUITING
Clinical Research Site
Fremont, California 94538 - United States
Status: RECRUITING
Clinical Research Site
Fresno, California 93720 - United States
Status: RECRUITING
Clinical Research Site
Fresno, California 93720 - United States
Status: RECRUITING
And 322 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE3 clinical trial for Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships